0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Xeris Pharmaceuticals Inc - Trending symbols

Notifications

TypeNotificationDate
RSI OversoldOversold RSI (Relative Strength Index)2025-11-21



Trends

 2024-09-302024-12-312025-03-312025-06-302025-09-30
Net Debt 211,733-11,907199,82610,485210,311-12,373197,938-251,351-53,413
Income before Tax -19,06213,949-5,113-4,107-9,2207,292-1,9282,549621
Net Income -15,73810,625-5,113-4,107-9,2207,292-1,9282,549621
Other Stockholders Equity 610,25416,594626,8484,892631,7406,686638,426-668,016-29,590
EBIT -6,608-5,033-11,6415,349-6,292-4,984-11,27613,8662,590
EBITDA -3,349-5,078-8,4275,289-3,138-5,014-8,15213,8755,723
Operating Income -9,841-4,404-14,2456,058-8,187-4,706-12,89314,5721,679
Total Other Income Expense Net -4,538-3,076-7,6143,829-3,785-643-4,4285,032604
Total Stockholder Equity 13,64116,40730,048-16,40713,641-9,7763,865-10,647-6,782
Income Tax Expense -40869-3390-3391-33810,1119,773

Comments

How you think about this?

Leave a comment

Stay informed about Xeris Pharmaceuticals Inc.

Receive notifications about Xeris Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.